High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies
Authors:
- 4 January 2019
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 27 (8) , 3053-3059
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a devastating pain condition of cancer therapy that may force chemotherapy dose reduction or discontinuation. Since treatment options for CIPN are quite limited, we investigated the effect of 10% amitriptyline cream on neuropathic pain.Keywords
This publication has 14 references indexed in Scilit:
- Risk-reduction and treatment of chemotherapy-induced peripheral neuropathyExpert Review of Anticancer Therapy, 2017
- A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsSupportive Care in Cancer, 2014
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral NeuropathyJAMA, 2013
- Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical AmitriptylineCase Reports in Medicine, 2012
- Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case ReportCase Reports in Medicine, 2011
- High Doses of Topical Amitriptyline in Neuropathic Pain: Two Cases and Literature ReviewPain Practice, 2011
- Topical Amitriptyline in Post-Traumatic Neuropathic PainJournal of Pain and Symptom Management, 2011
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CASupportive Care in Cancer, 2010
- Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic SymptomsJournal of Pain and Symptom Management, 2008
- Painful Peripheral NeuropathiesCurrent Neuropharmacology, 2006